We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > UNITY Biotechnology

News List

Ascentage Pharma Announces New License with Unity Biotechnology pharmafocusasia
January 10, 2019
Ascentage Pharma, a global clinical-stage biopharmaceutical company dedicated to developing apoptosis-targeted therapies for cancers and other diseases....
Unity Biotechnology Looking to Infuse New Life through $85M IPO biospace
April 08, 2018
A company focused on aging-related ailments is looking to infuse new life into its coffers through an initial public offering.
UNITY Biotechnology, Inc. Completes $55 Million Series C Financing biospace
March 20, 2018
UNITY Biotechnology, Inc. ("UNITY"), a privately held biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today announced the closing of a $55 million Series C financing.